C V Starr & Co. Inc.
In its 13F for Q3 2025 (holdings as of September 30, 2025, filed November 12, 2025), C V Starr & Co. Inc. reported 5 stock positions worth $216.6 million. Its top holding was SPDR Gold Shares (GLD) at 62.7% of the portfolio, followed by iShares Core MSCI Dev MKTS (IDEV, 14.0%) and Vanguard S&P Mid-Cap 400 ETF (IVOO, 11.6%). Its holdings were unchanged from Q2 2025.
- Most Recent 13F
- Q2 2026
- Location
- NEW YORK, NY
- CIK
- 0001340459
- Portfolio Value
- $216.6M (Q3 2025)
- SEC Filing
- 0001140361-25-041427 ↗ filed Nov 12, 2025
Holdings Value
Holdings 5 stocks · $216.6M
| GLD SPDR Gold Shares | 62.66% | 381,723 | $135.7M | No change |
| IDEV iShares Core MSCI Dev MKTS | 14.02% | 378,787 | $30.4M | No change |
| IVOO Vanguard S&P Mid-Cap 400 ETF | 11.59% | 227,427 | $25.1M | No change |
| IJR iShares Core S&P Small-Cap E | 11.00% | 200,458 | $23.8M | No change |
| CELU Celularity Inc. Class A | 0.73% | 764,069 | $1.6M | No change |
Portfolio Sells Q2 2025 → Q3 2025
| None this quarter. | |||
Portfolio Buys Q2 2025 → Q3 2025
| None this quarter. | |||
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 5 | $187.3M | GLD, IDEV, IJR, IVOO, CELU |
| Q1 2026 | 5 | $191.8M | GLD, IDEV, IVOO, IJR, CELU |
| Q4 2025 | 5 | $182.0M | GLD, IDEV, IVOO, IJR, CELU |
| Q3 2025 | 5 | $216.6M | GLD, IDEV, IVOO, IJR, CELU |
| Q2 2025 | 5 | $192.4M | GLD, IDEV, IVOO, IJR, CELU |
| Q1 2025 | 5 | $129.8M | GLD, IEFA, MDY, VB, CELU |
| Q4 2024 | 6 | $128.1M | GLD, IEFA, VO, IJR, AMZN |